Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jan 15;305:123410. doi: 10.1016/j.saa.2023.123410. Epub 2023 Sep 26.
In this research, fluorogenic labelling followed by applying first-order derivative spectrofluorimetry for the developed fluorophore is discussed as an alternative, sensitive and selective analytical approach. Benoxinate, containing a primary amine and fluorescamine reagent were selected for the study. Then the proposed methodology relies on the reaction between the primary amine in benoxinate with fluorescamine that selectively reacts with primary amines to develop highly fluorescent products. The fluorescamine-benoxinate developed fluorophore is identified by its sharp first-order derivative peak at 465 nm following excitation at 386 nm in borate buffer, pH 8. The optimum reaction conditions were ascertained. Following ICH validation guidelines, the first order derivative of the relative fluorescence intensity for the developed fluorophore was linearly related to benoxinate concentration and ranged from 20.0 to 200.0 ng/mL with a detection limit of 3.36 ng/mL and a quantitation limit of 10.19 ng/mL, moreover, satisfying accuracy and precision values were obtained upon statistical analysis of results. The offered analytical method was successfully applied to quantify benoxinate in raw material and Benox® eye drops as a direct application to a commercial formulation.
在这项研究中,讨论了荧光标记后应用一阶导数荧光法对所开发的荧光团进行分析,这是一种替代的、灵敏和选择性的分析方法。选择了含有伯胺的苯氧卡因和荧光胺试剂进行研究。然后,所提出的方法依赖于苯氧卡因中的伯胺与荧光胺之间的反应,该反应选择性地与伯胺反应,从而开发出高荧光产物。在硼酸盐缓冲液,pH 值 8 中,通过激发在 386nm 处,荧光胺-苯氧卡因开发的荧光团被鉴定为具有尖锐的一阶导数峰,在 465nm 处。确定了最佳反应条件。根据 ICH 验证指南,开发的荧光团的一阶导数相对荧光强度与苯氧卡因浓度呈线性关系,范围为 20.0 至 200.0ng/mL,检测限为 3.36ng/mL,定量限为 10.19ng/mL,此外,通过对结果的统计分析获得了令人满意的准确度和精密度值。所提供的分析方法成功地应用于原料药和 Benox®滴眼液中苯氧卡因的定量,这是对商业制剂的直接应用。